Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?
Recruiting · NCT07418450 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
EBUS-TBNA
What this trial is about
During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer
- indication for mediastinal staging
Where it is running
1 location listed.
- Medical University of Vienna - Vienna, Austria